Rachel Wei

Rachel Wei has extensive experience in the biostatistics field, working in various roles at notable companies. Rachel started their career at Pfizer, Medivation, Amgen, and BioMarin in 2008 before moving on to BeiGene as Senior Director of Biostatistics in 2017. Rachel then transitioned to IGM Biosciences, Inc. as Head of Biometrics in 2021 and is currently serving as the VP of Biostatistics at Olema Oncology since 2023. Rachel'scareer progression demonstrates a consistent track record of leadership and expertise in the field.

Rachel Wei obtained a PhD in Biostatistics from the University of Michigan.